Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
76.94 USD | -0.88% | -1.51% | -0.56% |
Financials (USD)
Sales 2024 * | 1.16B | Sales 2025 * | 1.25B | Capitalization | 12.23B |
---|---|---|---|---|---|
Net income 2024 * | 180M | Net income 2025 * | 228M | EV / Sales 2024 * | 10.7 x |
Net Debt 2024 * | 166M | Net cash position 2025 * | 85.4M | EV / Sales 2025 * | 9.73 x |
P/E ratio 2024 * |
69.4
x | P/E ratio 2025 * |
55.5
x | Employees | 3,050 |
Yield 2024 * |
0.41% | Yield 2025 * |
0.41% | Free-Float | 99.03% |
Latest transcript on Bio-Techne Corporation
1 day | -1.52% | ||
1 week | +0.57% | ||
Current month | +0.57% | ||
1 month | -2.51% | ||
3 months | +0.70% | ||
6 months | +13.64% | ||
Current year | +0.61% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 57 | 18-04-29 |
James Hippel
DFI | Director of Finance/CFO | 53 | 14-03-31 |
Matthew McManus
COO | Chief Operating Officer | 55 | Jan. 07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 02-12-31 | |
Randolph Steer
BRD | Director/Board Member | 74 | 89-12-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 17-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.93% | 1 M€ | +0.84% | - | |
2.50% | 5 M€ | -1.80% | - | |
2.15% | 2 M€ | -.--% | ||
1.25% | 0 M€ | 0.00% | - | |
1.13% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 76.72 | -1.17% | 237 067 |
24-06-07 | 77.63 | -1.52% | 897,308 |
24-06-06 | 78.83 | -0.54% | 785,617 |
24-06-05 | 79.26 | +3.07% | 930,552 |
24-06-04 | 76.9 | -1.28% | 1,095,060 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.61% | 12.23B | |
+51.85% | 57.87B | |
+41.53% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+25.06% | 12.2B | |
-9.14% | 11.06B |
- Stock Market
- Equities
- TECH Stock